The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | Considerations in CLL with new treatments
Florence Cymbalista, MD, PhD, of Avicenne Hospital, Bobigny, France, discusses the unanswered questions in chronic lymphocytic leukemia (CLL), including considerations with new treatments, from the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain. Dr Cymbalista highlights factors surrounding the need for more long-term data, treatment sequencing and differing guidelines between countries.
